5Allen RP,Picchietti D, Hening WA,et al. Restless legs syndrome:diagnostic criteria, special considerations, and epidemiology. Areport from the restless legs syndrome diagnosis and epidemiologyworkshop at the National Institutes of Health. Sleep Med ,2003 ,4 :101-119.
6ha Manna G, Pizza F, Persici E, et al. Restless legs syndromeenhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysistreatment. Nephrol Dial Transplant,2011 ,26: 1976-1983.
7Trenkwalder C. Hestless-legs syndrome in primary care: countingpatients in Idaho. Lancet Neurol, 2004,3 : 83.
8de Oliveira MM,Conti CF,Valbuza JS,et al. The pharmacologicaltreatment for uremic restless legs syndrome : evidence-basedreview. Mov Disord ,2010 ,25 : 1335-1342.
9Sethi KD. Restless legs syndrome sees the light of day. LancetNeurol,2008,7 :564-565.
10Pereira JC Jr, Rocha e Silva IR, Pradella-Hallinan M. TransientWiUis-Ekbom's disease ( restless legs syndrome) during pregnancymay be caused by estradiol-mediated dopamine overmodulation.Med Hypotheses, 2013 ,80 : 205 -208.
